You are here

Texas Safe Drug Disposal Law Goes Into Effect January

DisposeRx helps with compliance

Texas ranked 12th in the country in the number of opioid-related overdose deaths in 2016 with 1,375, and second in the country for total health care costs from opioid misuse at nearly $2 billion per year.

In July, Texas Governor Greg Abbott signed into law HB 2088, which requires that all pharmacists who dispense Schedule II controlled substances provide written notice on the safe disposal of controlled substances unless the dispensing pharmacy is authorized to take back those drugs for disposal, regularly accepts those drugs for safe disposal or provides the patient—at no cost—"chemicals to render the unused drugs unusable" or a mail-in pouch. This law goes into effect on January 1, 2020.

DisposeRx, which has a network of more than 2,000 pharmacies in Texas, is working to help pharmacists and pharmacies comply with HB 2088 via safe, at-home disposal packets and patient education.

DisposeRx packets are composed of materials that are FDA-approved for oral medications. The active ingredient in the medication is chemically and physically isolated in a polymer gel when water and the DisposeRx powder are added to a prescription vial and shaken. Patients can use the product with pills, tablets, capsules, liquids and powders and can then throw away the vial in the household trash.

DisposeRx packets are currently available in pharmacies throughout Texas including Albertson's, H-E-B, Kroger/Harris Teeter, Walgreen's and Walmart/Sam's Club, with more retail pharmacies being added later this year and early 2020, including Health Mart and CVS.

The Texas State Board of Pharmacy will be required to keep a list of locations at which controlled substance prescription drugs are accepted for safe disposal and must make that list available on the Board's website.

Source: DisposeRx, December 

Recent Headlines

Despite older, sicker patients, mortality rate fell by a third in 10 years
Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs
Acasti reports disappointing results for a second Omega-3-based drug
Declining lung cancer mortality helped fuel the progress